Simplex Trading, LLC Gilead Sciences, Inc. Transaction History

Simplex Trading, LLC

$2.98 Billion
Q2 2024

A detailed history of Simplex Trading, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Simplex Trading, LLC holds 152,442 shares of GILD stock, worth $12.7 Million. This represents 0.35% of its overall portfolio holdings.

Number of Shares

152,442

Previous 101,243 50.57%

Holding current value

$12.7 Million

Previous $7.42 Million 41.03%

% of portfolio

0.35%

Previous 0.22%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 25, 2024	BUY	$63.15 - $72.88 $3.23 Million - $3.73 Million	51,199 Added 50.57%	152,442 $10.5 Million
Q1 2024 Apr 25, 2024	BUY	$71.58 - $87.29 $7.25 Million - $8.84 Million	101,243 New	101,243 $7.42 Million
Q3 2023 Nov 01, 2023	SELL	$73.94 - $80.67 $3.22 Million - $3.51 Million	-43,557 Reduced 35.61%	78,758 $5.9 Million
Q2 2023 Aug 04, 2023	BUY	$76.01 - $86.7 $9.3 Million - $10.6 Million	122,315 New	122,315 $9.43 Million
Q2 2022 Aug 03, 2022	BUY	$57.72 - $65.01 $2.9 Million - $3.27 Million	50,325 New	50,325 $3.11 Million
Q1 2022 May 02, 2022	SELL	$57.92 - $72.58 $3.98 Million - $4.99 Million	-68,715 Closed	0 $0
Q4 2021 Feb 23, 2022	SELL	$64.88 - $73.64 $2.71 Million - $3.08 Million	-41,827 Reduced 37.84%	68,715 $4.99 Million
Q3 2021 Oct 28, 2021	BUY	$67.69 - $73.03 $1.58 Million - $1.71 Million	23,394 Added 26.84%	110,542 $7.64 Million
Q2 2021 Aug 12, 2021	SELL	$63.47 - $69.35 $3.37 Million - $3.68 Million	-53,052 Reduced 37.84%	87,148 $6 Million
Q1 2021 Apr 26, 2021	SELL	$60.0 - $68.46 $7.51 Million - $8.57 Million	-125,188 Reduced 47.17%	140,200 $0
Q4 2020 Feb 02, 2021	BUY	$56.65 - $64.55 $15 Million - $17.1 Million	265,388 New	265,388 $15.5 Million
Q3 2020 Oct 14, 2020	SELL	$62.1 - $78.08 $6,210 - $7,808	-100 Closed	0 $0
Q2 2020 Jul 13, 2020	SELL	$72.34 - $84.0 $11.6 Million - $13.5 Million	-160,871 Reduced 99.94%	100 $7,000
Q1 2020 Apr 29, 2020	BUY	$62.63 - $80.22 $1.48 Million - $1.89 Million	23,574 Added 17.16%	160,971 $12 Million
Q4 2019 Feb 05, 2020	BUY	$61.62 - $67.78 $4.09 Million - $4.5 Million	66,439 Added 93.63%	137,397 $8.93 Million
Q3 2019 Oct 15, 2019	BUY	$62.51 - $69.0 $3.91 Million - $4.31 Million	62,532 Added 742.13%	70,958 $4.5 Million
Q2 2019 Jul 26, 2019	SELL	$61.87 - $69.38 $1.81 Million - $2.03 Million	-29,291 Reduced 77.66%	8,426 $569,000
Q1 2019 Apr 18, 2019	BUY	$62.53 - $70.05 $1.18 Million - $1.32 Million	18,841 Added 99.81%	37,717 $0
Q4 2018 Jan 16, 2019	BUY	$60.54 - $79.0 $89,357 - $116,604	1,476 Added 8.48%	18,876 $1.18 Million
Q3 2018 Oct 23, 2018	SELL	$71.28 - $78.92 $2.25 Million - $2.49 Million	-31,606 Reduced 64.49%	17,400 $1.34 Million
Q2 2018 Jul 30, 2018	BUY	$64.88 - $75.68 $3.18 Million - $3.71 Million	49,006 New	49,006 $3.47 Million
Q1 2018 Apr 26, 2018	SELL	$72.84 - $88.8 $5.72 Million - $6.97 Million	-78,525 Closed	0 $0
Q4 2017 Jan 10, 2018	BUY	$71.15 - $83.52 $5.59 Million - $6.56 Million	78,525	78,525 $5.63 Million

Others Institutions Holding GILD

# of Institutions

1,879

Shares Held

1.02B

Call Options Held

12M

Put Options Held

8.96M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $104B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Simplex Trading, LLC with notifications on news.

Account

Simplex Trading, LLC Gilead Sciences, Inc. Transaction History